# LifeStance Reports Third Quarter 2025 Results
Canonical URL: https://biopharmsignal.com/news/LFST/lifestance-reports-third-quarter-2025-results
Ticker: LFST
Company: LifeStance Health
Source: LifeStance Health
Published: 2025-11-06 11:00 EST
Original Source URL: https://investor.lifestance.com
## Summary

SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the third quarter ended September 30, 2025.

## Article Body
SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the third quarter ended September 30, 2025.
## Recent Company News
- 2026-05-08 02:18 EST — [LifeStance Health Group Announces Pricing of Secondary Public Offering](https://biopharmsignal.com/news/LFST/lifestance-health-group-announces-pricing-of-secondary-public-offering) — Source: LifeStance Health
- 2026-05-07 10:00 EST — [LifeStance Reports First Quarter 2026 Results](https://biopharmsignal.com/news/LFST/lifestance-reports-first-quarter-2026-results) — Source: LifeStance Health
- 2026-04-29 20:10 EST — [LifeStance to Present at Upcoming Investor Conferences](https://biopharmsignal.com/news/LFST/lifestance-to-present-at-upcoming-investor-conferences) — Source: LifeStance Health
- 2026-04-16 20:10 EST — [LifeStance to Host First Quarter 2026 Earnings Conference Call on May 7, 2026](https://biopharmsignal.com/news/LFST/lifestance-to-host-first-quarter-2026-earnings-conference-call-on-may-7-2026) — Source: LifeStance Health
- 2026-04-09 13:00 EST — [LifeStance Publishes Outcomes Data Validating the Benefit of Mental Health Treatment at Scale](https://biopharmsignal.com/news/LFST/lifestance-publishes-outcomes-data-validating-the-benefit-of-mental-health-treatment-at-scale) — Source: LifeStance Health
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)